Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism

Atherosclerosis
Danna M BreenAdria Giacca

Abstract

Revascularization procedures used for treatment of atherosclerosis often result in restenosis. Resveratrol (RSV), an antioxidant with cardiovascular benefits, decreases neointimal formation after arterial injury by a mechanism that is still not fully clarified. Our main objective was to address the role of nitric oxide synthases (NOSes) and more specifically the endothelial-NOS (eNOS) isoform as a mediator of this effect. RSV (4 mg/kg/day, s.c.) alone or in combination with the NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME) (2 mg/kg/day, s.c.) was given to Sprague-Dawley rats beginning at 3 days before arterial (carotid or aortic) injury. RSV reduced neointimal formation by 50% (P<0.01), decreased intimal cell proliferation by 37% (P<0.01) and reduced inflammatory markers such as PECAM and MMP-9 mRNA. These effects of RSV were all abolished by coadministration of l-NAME. Oral RSV (beginning at 5 days before arterial injury) reduced neointimal thickness after femoral wire injury in mice, however this effect was not observed in eNOS knockout mice. This is the first report of RSV decreasing neointimal cell proliferation and neointimal growth through an eNOS-dependent mechanism.

References

Feb 1, 1996·Journal of Vascular Surgery·M I EllenbyA G Scicli
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jean-Francois MarierMurray P Ducharme
Mar 8, 2005·The Journal of Biological Chemistry·Margie T BorraJohn M Denu
Sep 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ilwola MattagajasinghKaikobad Irani
Sep 12, 2008·European Journal of Applied Physiology·M Brennan HarrisRichard C Venema
May 11, 2010·The Biochemical Journal·Barbara CalaminiAndrew D Mesecar
Feb 4, 2011·The Journal of Clinical Endocrinology and Metabolism·Husam GhanimParesh Dandona

❮ Previous
Next ❯

Citations

Mar 4, 2014·Lipids in Health and Disease·Dongdan ZhengWeiyi Mai
Sep 23, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vernon W Dolinsky, Jason R B Dyck
Jul 25, 2015·Annals of the New York Academy of Sciences·Miranda M Sung, Jason R B Dyck
May 28, 2013·Biochimica Et Biophysica Acta·Vernon W DolinskyJason R B Dyck
Jun 13, 2015·Journal of Diabetes Research·Gabriele TogliattoMaria Felice Brizzi
Feb 6, 2015·Biochimica Et Biophysica Acta·Eun-Jung Park, John M Pezzuto
Dec 3, 2014·Biochimica Et Biophysica Acta·Beshay N M ZordokyJason R B Dyck
Sep 13, 2013·American Journal of Hypertension·Rena M Pollack, Jill P Crandall
Feb 17, 2017·International Journal of Experimental Pathology·Francesca BonominiRita Rezzani
May 12, 2019·International Journal of Molecular Sciences·Stefanie KamannJörg Schnorr
Mar 10, 2020·Canadian Journal of Physiology and Pharmacology·Chris R TriggleMorley D Hollenberg
Jul 4, 2018·Cardiovascular and Interventional Radiology·Ulrich SpeckStephanie Bettink
Jun 21, 2019·The Journal of Clinical Endocrinology and Metabolism·Fatimo BiobakuParesh Dandona
Sep 24, 2021·Critical Reviews in Food Science and Nutrition·Mamali DasSeyed Mohammad Nabavi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here